GE HEALTHCARE FDA Approval NDA 022066

NDA 022066

GE HEALTHCARE

FDA Drug Application

Application #022066

Documents

Letter2007-09-07
Letter2013-08-29
Letter2012-12-13
Letter2014-11-18
Label2007-09-07
Label2010-12-20
Label2013-08-28
Label2014-11-20
Review2008-10-03
Other Important Information from FDA2007-09-24
Letter2010-12-22
Summary Review2008-10-03
Label2018-04-27
Medication Guide2018-04-27
Letter2018-05-01
Label2018-11-06
Letter2018-11-08
Letter2019-10-24
Label2019-10-24

Application Sponsors

NDA 022066GE HEALTHCARE

Marketing Status

Discontinued001
Prescription002

Application Products

001INJECTABLE;INJECTION14.35GM/50ML (287MG/ML)0OMNISCANGADODIAMIDE
002INJECTABLE;INJECTION28.7GM/100ML (287MG/ML)1OMNISCANGADODIAMIDE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2007-09-05STANDARD
LABELING; LabelingSUPPL2AP2010-12-20UNKNOWN
LABELING; LabelingSUPPL4AP2013-08-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2014-05-14N/A
LABELING; LabelingSUPPL6AP2012-12-11STANDARD
LABELING; LabelingSUPPL7AP2014-11-14STANDARD
LABELING; LabelingSUPPL8AP2018-04-26STANDARD
LABELING; LabelingSUPPL9AP2018-11-07STANDARD
LABELING; LabelingSUPPL10AP2019-10-23STANDARD

Submissions Property Types

SUPPL2Null7
SUPPL4Null6
SUPPL5Null4
SUPPL6Null0
SUPPL7Null15
SUPPL8Null31
SUPPL9Null6
SUPPL10Null6

CDER Filings

GE HEALTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22066
            [companyName] => GE HEALTHCARE
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022066s008lbl.pdf#page=1"]
            [products] => [{"drugName":"OMNISCAN","activeIngredients":"GADODIAMIDE","strength":"14.35GM\/50ML (287MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"OMNISCAN","activeIngredients":"GADODIAMIDE","strength":"28.7GM\/100ML (287MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"10\/23\/2019","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/022066s010lbl.pdf\"}]","notes":""},{"actionDate":"11\/07\/2018","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020123s047,022066s009lbl.pdf\"}]","notes":""},{"actionDate":"04\/26\/2018","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022066s008lbl.pdf\"}]","notes":""},{"actionDate":"11\/14\/2014","submission":"SUPPL-7","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022066s007,020123s043lbl.pdf\"}]","notes":""},{"actionDate":"08\/27\/2013","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022066s00420123s039lbl.pdf\"}]","notes":""},{"actionDate":"12\/20\/2010","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022066s002lbl.pdf\"}]","notes":""},{"actionDate":"09\/05\/2007","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/022066lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"OMNISCAN","submission":"GADODIAMIDE","actionType":"14.35GM\/50ML (287MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"OMNISCAN","submission":"GADODIAMIDE","actionType":"28.7GM\/100ML (287MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.